.jpg)
Faecal microbiota signature for pancreatic cancer
Patent number:
WO2023/052486
No items found.
The CNIO has developed a method for early detection of pancreatic cancer. The inventors have found a method for early diagnosing pancreatic cancer based on a faecal microbiota signature with high specificity for pancreatic cancer.
Countries:
Spain
Regions:
Community of Madrid
Centers:
CNIO, FUNDACION CNIO
Other entities:
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
The method of the invention is a sensitive, specific and non-invasive method for an early detection of pancreatic cancer, in particular Pancreatic Ductal Adenocarcinoma (PDAC) that could therefore improve survival outcomes. The present invention refers to a method for diagnosing pancreatic cancer in a subject comprising determining the abundance of several Microbiome species in a faecal sample from said subject, as well as to a kit and its use for the diagnosis of pancreatic cancer.
Comments